Literature DB >> 8243485

Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis.

Q He1, J Mertsola, J P Himanen, O Ruuskanen, M K Viljanen.   

Abstract

Six different antigen preparations for use in an enzyme immunoassay (EIA) to detect IgM, IgA and IgG antibodies to Bordetella pertussis were evaluated using sera from 13 randomly selected culture-positive patients and from 87 patients with suspected pertussis during a pertussis outbreak. Based on results in 80 healthy control sera a specificity limit of 99.9% was selected. Sera from all culture-positive patients reacted with at least one of the antigens. The sensitivity of the EIA using the individual antigen preparations was 85% for filamentous hemagglutinin, 92% for pertussis toxin, 62% for 69 kDa outer membrane protein, 85% for a pool of these three antigens, 54% for sonicated whole bacteria and 69% for 21 kDa pertussis toxin subunit S1. In the outbreak patient group 49 (56%) of the initial sera reacted with at least one of five antigen preparations. The EIA using sonicated bacteria detected only 41% of all seropositive cases compared with 51% using filamentous hemagglutinin, 61% using pertussis toxin, 65% using 69 kDa OMP and 65% using pooled antigen. It is concluded that either the pooled antigen or pertussis toxin antigen are suitable antigen preparations for use in the EIA for diagnosis of pertussis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243485     DOI: 10.1007/bf02009381

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Enrichment medium for the isolation of Bordetella.

Authors:  J Regan; F Lowe
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

2.  Evaluation of serologic assays for diagnosis of whooping cough.

Authors:  G Granström; B Wretlind; C R Salenstedt; M Granström
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

3.  Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis.

Authors:  S A Halperin; R Bortolussi; A J Wort
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

4.  A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled.

Authors:  R W Steketee; D G Burstyn; S G Wassilak; W N Adkins; M B Polyak; J P Davis; C R Manclark
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

5.  Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA).

Authors:  M K Viljanen; O Ruuskanen; C Granberg; T T Salmi
Journal:  Scand J Infect Dis       Date:  1982

6.  Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis.

Authors:  Q He; J Mertsola; H Soini; M Skurnik; O Ruuskanen; M K Viljanen
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Diagnosis of whooping cough: comparison of serological tests with isolation of Bordetella pertussis. A combined Scottish study.

Authors: 
Journal:  Br Med J       Date:  1970-12-12

8.  Immunogenicity and protective efficacy of pertussis toxin subunit S1 produced by Bacillus subtilis.

Authors:  R M Olander; A Muotiala; J P Himanen; M Karvonen; U Airaksinen; K Runeberg-Nyman
Journal:  Microb Pathog       Date:  1991-02       Impact factor: 3.738

9.  Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay.

Authors:  J Mertsola; O Ruuskanen; T Kuronen; O Meurman; M K Viljanen
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

10.  Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.

Authors:  D G Burstyn; L J Baraff; M S Peppler; R D Leake; J St Geme; C R Manclark
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  7 in total

1.  Update of epidemiology, diagnosis, and treatment of pertussis.

Authors:  J E Hoppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

Review 2.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Authors:  K Kösters; M Riffelmann; B Dohrn; C H von König
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

4.  Rapid diagnosis of pertussis in young infants: comparison of culture, PCR, and infant's and mother's serology.

Authors:  E Grimprel; E Njamkepo; P Bégué; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

5.  Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Authors:  M Riffelmann; K Thiel; J Schmetz; C H Wirsing von Koenig
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

6.  Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection.

Authors:  Q He; K Edelman; H Arvilommi; J Mertsola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

7.  Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations.

Authors:  Aapo Knuutila; Tine Dalby; Alex-Mikael Barkoff; Charlotte Sværke Jørgensen; Kurt Fuursted; Jussi Mertsola; Kevin Markey; Qiushui He
Journal:  Clin Transl Immunology       Date:  2020-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.